Increased levels of copeptin before clinical diagnosis of preelcampsia.
about
G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and preventionCopeptin testing in acute myocardial infarction: ready for routine use?An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.Vasopressin: the missing link for preeclampsia?Preeclampsia and Pregnancy-Related Hypertensive DisordersIntroduction to the American Heart Association's Hypertension Strategically Focused Research Network.Muscle sympathetic nerve activity and volume regulating factors in healthy pregnant and non-pregnant women.Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.Retinol-Binding Protein 4 and Lipids Prospectively Measured During Early to Mid-Pregnancy in Relation to Preeclampsia and Preterm Birth Risk.New Models of Pregnancy-Associated Hypertension.Maternal serum markers of lipid metabolism in relation to neonatal anthropometry.Endogenous Ouabain: Recent Advances and ControversiesCopeptin: a new biomarker that is specific for preeclampsia?Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?Angiotensin AT1A Receptors Expressed in Vasopressin-Producing Cells of the Supraoptic Nucleus Contribute to the Osmotic Control of Vasopressin.Identification of patients at risk for preeclampsia with the use of uterine artery Doppler velocimetry and copeptin.
P2860
Q26744192-FD1FDAF5-A707-464E-B808-DD9098F38C6CQ35556651-DBB104CE-92B3-446D-AC92-98A2786A1935Q36112146-FC6EFB6A-BDA5-4542-8ACE-C85848E47F5DQ36339353-AD52A444-8E77-4838-B5EB-603D2FABD9CEQ36584747-28B867F0-842C-49BC-9AB9-6A779A116C21Q37469821-8F4B9E1E-F394-41C7-9472-EA5015BF4602Q38667227-993ABCF8-095E-44E6-80B8-A3377683486CQ38843567-EC12302A-3C2C-4322-8ABF-EBD1B203B151Q38879727-7A2A7702-E771-41A4-B90E-57523428FA23Q39283914-CC8B41AB-A0BC-49B5-A9C2-7CCF8981B83BQ40278518-23265520-FFA4-45C5-BC96-19F8ED5E8205Q41923007-5C9D7679-63C5-4BB1-82A2-362C21A21448Q43164120-B2777AB0-0766-463B-A7B8-EAD26AD5422EQ46306526-EB08B890-6353-40AE-9898-CBC50657ACA2Q47702892-03E44947-549D-4088-8291-4D78B5AA4728Q53749818-E21F6667-9F90-4F16-9D78-27088F86D5D5
P2860
Increased levels of copeptin before clinical diagnosis of preelcampsia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@en
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@nl
type
label
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@en
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@nl
prefLabel
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@en
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@nl
P2860
P50
P1433
P1476
Increased levels of copeptin before clinical diagnosis of preelcampsia.
@en
P2093
Zhaohui Lu
P2860
P304
P356
10.1161/HYPERTENSIONAHA.114.03762
P407
P577
2014-09-15T00:00:00Z